Avoid Pharma & IT stocks. They are out of favour. Pharma were beneficiaries of a short term Covid cycle whose demand drivers are now gone. IT stocks are facing slowdown in the USA. valuations are high & will correct
Underweight on Pharma stocks
Ravi Dharamshi of ValueQuest Investment Advisors disclosed that his Fund is underweight Pharma stocks because their growth prospects are subdued. He explained that the sector was a beneficiary of a short term boom cycle…
Avoid investing in Pharma & IT stocks. They are now out of favour: Ravi Dharamshi
| Subscribe To Our Free Newsletter |
